Authors

Randy Dotinga

Randy Dotinga is a medical writer based in San Diego, Calif.

Latest Article

Isotretinoin: Time to reconsider blood test best practices

While oral isotretinoin has been associated with various side effects and routine blood tests have been recommended, evidence points to inconsistencies in monitoring practices. Many physicians also are questioning whether the effort has value.

Darin Painter
Latest Article

Are you missing this business tool?

Balancing a career or business, a family and a household is a given for many of us. When it comes to keeping cool and maintaining relationships with family, colleagues and our patients, communication and education are key. Here's how one tool can help.

Sandy Johnson, M.D.
Latest Article

Antibiotic dialogue needs to continue

I thoroughly enjoyed the lead article about “antimicrobial stewardship” in the October edition of Dermatology Times (“Antimicrobial stewardship: How dermatologists can be part of the solution, Vol. 34, No. 10). It succinctly and effectively detailed that for healthcare providers in general and dermatologists in specific, it is our duty to utilize antimicrobials appropriately.

Bill Gillette
Latest Article

Laser technology creates hi-res maps of acne lesions

An exploration of the feasibility of using laser technology to detect changes in microvasculature during the acne lesion healing progress and to introduce a microvasculature-based biomarker in evaluating the treatment and grading of acne.

Andrew D. Bowser
Latest Article

Combination therapy improves survival in melanoma

The combination of encorafenib plus binimetinib significantly improved overall survival versus vemurafenib in patients with BRAF-mutant melanoma, updated results of the randomized, phase three COLUMBUS trial show.

Eliot F. Battle, Jr., M.D.

CEO and Co-Founder, Cultura Dermatology and Laser Center, Washington, D.C.

Latest Article

Skin of Color Seminar Series roundup

A panel discussion on the increasing trend of total body skin lightening ― and ethical and health concerns associated with skin lightening ― was this year's most discussesd and controversial topic.

Cheryl Bisera
Latest Article

Self-care Before Patient Care : 10 Ways to Boost Your Resilience in 2018 - Part 2

In April we reviewed the first five tips to help boost your resilience and well being in 2018. Below are the final five in the second part of this two-part article.

Jeff Craven
Latest Article

More new therapies under study for underarm sweat

Qbrexza was approved earlier this year for primary axillary hyperhidrosis. And, now, other treatments are under study. In his presentation at this week’s Fall Clinical Dermatology Conference in Las Vegas, Dr. David Pariser summarizes the latest research.

Justin Knott, president, Intrepy Healthcare Marketing
Latest Article

8 Ways to improve Instagram results

Marketing expert Justin Knott explains how to grow your Instagram following as part of a successful digital practice marketing strategy.

Anna Sarno Ryan, M.D.
Latest Article

The journey begins when the trip ends

WE medical trip to India ends in eye-opening lessons learned.

Andrew Frankel, Chief Operating Officer, Pennsylvania Dermatology Partners, Philadelphia
Latest Article

Technology: A private practice’s best friend

Pennsylvania Dermatology Partners tells its story of technological support and success.

Galadriel Bonnel, Ph.D., FNP
Latest Article

Life-threatening emergency cases in dermatology

Life-threatening emergency cases may be rare, but they can be complex. At EADV this week, experts review cases physicians should be aware of.

Nia Cason
Latest Article

A review of treatment for dermatofibrosarcoma

Dermatofibrosarcoma is a common, but unusual locally aggressive cutaneous tumor. Its characteristic tentacle can grow into surrounding fat, muscle and even bone. For dermatologists this means that understanding treatment options is a priority, says a physician reporting from EADV 2018.

Steve Xu, MD, MSc, FAAD
Latest Article

Benzene Concerns in Benzoyl Peroxide Spark Calls for Safer Acne Treatment Standards

As news of benzene contamination in benzoyl peroxide products continues to raise safety discussions, Steve Xu, MD, MSc, advocates for stricter regulations, increased research, and the consideration of safer acne treatment alternatives.

William Ju., M.D., FAAD
Latest Article

Continuing the innovation journey

In recognition of the first anniversary of our Innovation column, Drs. Steve Xu and William Ju reflect on the range of topics covered throughout the year and highlight what's to come.

Padma Nagappan
Latest Article

Good skin health and a diverse microbiome go hand-in-hand

Cosmetic products with prebiotics, probiotics and postbiotics may be beneficial in treating eczema, a physician reported at the Fall Clinical Dermatology Conference held earlier this month in Las Vegas.

Jeff Craven
Latest Article

Treatment options for benign lesions

Patients are increasingly seeking to have benign lesions removed and today, there are a number of treatment options available to safely and effectively remove unwanted lesions. Suneel Chilukuri, M.D., reviewed these options during a presentation at the Fall Clinical Dermatology Conference held this week in Las Vegas.

Nadia M. Whitehead
Latest Article

Botulinum toxin injections may improve scarring

Long lauded for its ability to reduce the appearance of wrinkles, botulinum toxin is now being considered for reducing scarring.

Morgan Nguyen, BA
Latest Article

Medical societies can support innovation

In this month's Innovation column, Steve Xu, M.D. and Morgan Nguyen discuss how to incorporate innovation into medical societies.

Joseph E. Guimera
Latest Article

Steps to mitigate cyber risk

The use of cloudbased platforms to send, receive and store patient data in teledermatology adds security risks.

Bruce E. Katz, M.D.
Latest Article

Optimize clinical trial recruitment with digital platforms

Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.

Aleksander Eiken, M.D.
Latest Article

Optimize clinical trial recruitment with digital platforms

Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.

Valerija Misev, M.D.
Latest Article

Optimize clinical trial recruitment with digital platforms

Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.

John Robert Zibert, M.SC., Ph.D
Latest Article

Optimize clinical trial recruitment with digital platforms

Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.

Katja Reuter, Ph.D.
Katja Reuter, Ph.D.
Latest Article

Improving the reporting of social media recruitment for clinical trials

In this article, Katja Reuter, Ph.D. critiques a study by Katz and colleagues on the effectiveness of using digital platforms to recruit for an atopic dermatitis study. 

David Ozeri, M.D.
Latest Article

Palmoplantar pustulosis rare, linked to psoriasis

Researchers recently undertook an epidemiologic study to investigate the prevalence of palmoplantar pustulosis (PPP) and co-existing plaque psoriasis. Read what they discovered in this article.

Michael L. Sierra, Ph.D.
Latest Article

Opportunities for collaboration with industry

Industry relationships are essential for innovation in dermatology. In this month's column, Steve Xu, M.D., and Michael L. Sierra, Ph.D., provide their insight on collaborating with industry.

Maria L. Espinosa, B.S.
Maria L. Espinosa, B.S.
Latest Article

Skin issues that affect patients with skin of color

Healthcare disparities exist in all fields of medicine, including dermatology. We seek to address these disparities in this article by outlining the differences in epidemiology, presentation, access and outcomes of five conditions in patients with skin of color.

Raymond A. Miller, J.D.
Latest Article

How to use patents to maximize value for your venture

In this follow up to last month’s Innovations column on intellectual property and technology transfer, Raymond A. Miller, J.D., and Steve Xu, M.D., FAAD discuss how to utilize patents to maximize value for your venture.

Stephen Huber
Latest Article

Basal cell carcinoma treatments on the horizon

In this pipeline report, Dermatology Times presents insights into Hh pathway inhibitors currently in phase 2 and phase 3 for the treatment of basal cell carcinoma.